13C MR reporter probe system using dynamic nuclear polarization

NMR in Biomedicine

Volumn 24, Issue 5, 2011, Pages 514-520

  Chen, Albert P ^a   Hurd, Ralph E ^b   Gu, Yi ping ^c   Wilson, David M ^d   Cunningham, Charles H ^c,e  

^a GE HEALTHCARE   (Canada)

^b GE HEALTHCARE   (United States)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

13C MRS; Aminocylase 1; Cell; Dynamic nuclear polarization (DNP); Reporter probe

Indexed keywords

13C MRS; AMINOCYLASE-1; CELL DETECTION; CELLULAR THERAPY; DYNAMIC NUCLEAR POLARIZATION; DYNAMIC NUCLEAR POLARIZATION (DNP); HEK293 CELLS; HIGH RESOLUTION VISUALIZATION; IMAGING TOOLS; IN-CONTROL; IN-VIVO; MR SCANNERS; PROBE SYSTEMS; PROOF OF CONCEPT; PURIFIED PROTEIN; REPORTER GENE; REPORTER PROBE; REPORTER SYSTEMS; STRONG SIGNAL;

ACETYLATION; AMINO ACIDS; CELLS; ENZYME ACTIVITY; GENES; PROBES; SPIN POLARIZATION; VISUALIZATION;

NUCLEAR MAGNETIC RESONANCE;

AMINOACYLASE; N ACETYLMETHIONINE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL STRAIN HEK293; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVITY; ENZYME PURIFICATION; FEASIBILITY STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL;

AMIDOHYDROLASES; BLOTTING, WESTERN; CARBON ISOTOPES; GENES, REPORTER; HEK293 CELLS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; SUBSTRATE SPECIFICITY; TIME FACTORS; TRANSFECTION;

EID: 79958797687     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1618     Document Type: Article

References (24)

1. Lee Z, Dennis JE, Gerson SL. Imaging stem cell implant for cellular-based therapies. Exp. Biol. Med. 2008; 233: 930-940.
2. Akins EJ, Dubey P. Noninvasive imaging of cell-mediated therapy for treatment of cancer. J. Nucl. Med. 2008; 49 (6 (Suppl)): 180S-195S.
3. Gilad AA, Winnard PTJ, van Zijl PCM, Bulte JWM. Developing MR reporter genes: promises and pitfalls. NMR Biomed. 2006; 20: 275-290.
4. 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene. Proc. Natl. Acad. Sci. 2001; 98: 5205-5210.
5. Cui W, Otten P, Li Y, Koeneman K, Yu J, Mason R, Novel, NMR approach to assessing gene transfection: 4-fluoro-2-nitrophenyl-beta-D-galactopyranoside as a prototype reporter molecule for beta-galactosidase. Magn. Reson. Med. 2004; 51: 616-620.
6. Stegman L, Rehemtulla A, Beattie B, Kievit E, Lawrence T, Blasberg R, Tjuvajev J, Ross B. Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. 1999; 96: 9821-9826.
7. Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of >10, 000 times in liquid-state NMR. Proc. Natl. Acad. Sci. USA, 2003; 100: 10, 158-10, 163.
8. 13C magnetic resonance imaging and spectroscopy. Nat. Med. 2007; 13: 1382-1387.
9. Cunningham CH, Chen AP, Lustig M, Hargreaves BA, Lupo J, Xu D, Kurhanewicz J, Hurd RE, Pauly JM, Nelson SJ, Vigneron DB. Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. J. Magn. Reson. 2008; 193: 139-146.
10. 13C magnetic resonance spectroscopy. Faseb J. 2009; 23: 2529-2538.
11. 13C-labeled glutamine. Magn. Reson. Med. 2008; 60: 253-257.
12. 13C MRSI studies. Magn. Reson. Imaging, 2008; 26: 721-726.
13. Deichmann R, Hahn D, Haase A, Fast, T1 mapping on a whole-body scanner. Magn. Reson. Med. 1999; 42: 206-209.
14. Koopman G, Reutelingsperger C, Kuijten G, Keehnen R, Pals S, van Oers M. Annexin V for flow cytometric detection of phosphatidylserine expression on B cell undergoing apoptosis. Blood, 1994; 84: 1415-1420.
15. Nicoletti I, Migliorati G, Pagliacci MFG, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 1991; 139: 271-279.
16. 13C. J. Magn. Reson. 2007; 287: 357-362.
17. 129Xe MR. J. Magn. Reson. B, 1996; 113: 179-183.
18. Golman K, Ardenkjaer-Larsen JH, Peterson JS, Mansson S, Leunbach I. Molecular imaging with endogenous substances. Proc. Natl. Acad. Sci. USA, 2003; 100: 10, 435-10, 439.
19. Lindner H, Höpfner S, Täfler-Naumann M, Miko M, Konrad L, Röhm K. The distribution of aminoacylase I among mammalian species and localization of the enzyme in porcine kidney. Biochimie, 2000; 82: 129-137.
20. Lindner H, Täfler-Naumann M, Röhm K. N-Acetylamino acid utilization by kidney aminoacylase-1. Biochimie, 2008; 90: 773-780.
21. Mitz MA, Schlueter RJ. Direct spectrophotometric measurement of the peptide bond: application to the determination of acylase I. Biochim. Biophys. Acta, 1958; 27: 168-172.
22. Henseling J, Rohm KR. Unusual solvent isotope effects of the aminoacylase-catalyzed hydrolysis of acetylamino acids. FEBS Lett. 1987; 219: 27-30.
23. Sigma-Aldrich. Material Safety Data Sheet: Sigma-D5511. Sigma-Aldrich: St. Louis, MO, USA 2009.
24. 13C]pyruvic acid at 4.6 tesla. J. Magn. Reson. 2009; 197: 167-175.